ThursdayMay 19, 2022 9:45 am

Flora Growth Corp. (NASDAQ: FLGC), A Company Revolutionizing the Plant-Based Wellness and Lifestyle Industry

Flora Growth has been building a design-led collective of plant-based wellness and lifestyle brands Through the work done by its pharma division, the company earned over $31.5 million in gross proceeds in the year ended November 2021 The company still maintains its revenue guidance projection of $35-45 million for 2022, attributed mainly to product diversification initiatives, strengthening its supply chain, and adoption of cost-effective cultivation practices Since its inception, Flora Growth (NASDAQ: FLGC) has remained committed to building a design-led collective of plant-based wellness and lifestyle brands. This objective has defined Flora Growth’s three central pillars- wholesale cannabis, pharmaceutical cannabis,…

Continue Reading

ThursdayMay 19, 2022 9:00 am

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Adds Neuro-enhancing Therapies to 6 KWC Clinics, With Plans to Expand Across the Nation

Delic Holdings Corp works to develop novel solutions for hard-to-treat mental and emotional disorders The company’s Ketamine Wellness Centers (“KWC”) clinical subsidiary recently announced the addition of NAD+ (nicotinamide adenine dinucleotide) infusion therapies as a means of boosting natural energy stores and immunity, brain and DNA function, and cell communication The NAD+ therapies will launch in six of KWC’s clinics on May 9 — in Jacksonville, Fla.; Houston and Dallas, Texas; Salt Lake City, Utah; Las Vegas, Nev.; and Tucson, Ariz. KWC intends to expand the treatment to additional clinics across the country in the coming months Delic Holdings (CSE:…

Continue Reading

WednesdayMay 18, 2022 2:23 pm

QualityStocksNewsBreaks – Laredo Oil Inc. (LRDC) Expanding Mineral Rights Acreage to Leverage Potential of Montana Property

Laredo Oil (OTC: LRDC) was recently granted a permit for planned drilling, starting with its first well, the Olfert 11-4, at a property located in the Western Williston Basin of Montana acquired by Laredo’s subsidiary, Lustre Oil Company LLC. A recent article quotes company CEO and Chair Mark See as saying, “Assuming successful economic results from the completion of the first well, we intend to proceed to drill the next ten wells, contingent upon successful completion of the fundraising efforts currently underway… And we are continuing to expand our mineral rights acreage portfolio in Montana to more fully realize the…

Continue Reading

WednesdayMay 18, 2022 2:10 pm

QualityStocksNewsBreaks – Why Home Bistro Inc. (HBIS) Is ‘One to Watch’

Home Bistro (OTC: HBIS), a Miami-based online meal delivery platform that offers celebrity chef-inspired and ready-made meals, is on a mission to lead the next generation of heat-to-eat food delivery with unique and delicious cuisine and an experience that excites the market. Home Bistro offers a family of high-quality, direct-to-consumer, gourmet meals, addressing the three problems facing the prepared food delivery market: poor food quality; customers tired of eating the same meals; and the fact that eating at home is still eating at home, with the accompanying food preparation and clean up chores. “In mid-2021, Home Bistro acquired southern-California based…

Continue Reading

WednesdayMay 18, 2022 12:57 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Several New Hires as Key to EV Programs, Bright Future

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, on Tuesday announced several new hires across vehicle engineering, vehicle integration, powertrain systems and manufacturing in support of EV vehicle programs. Mullen’s CEO and Chairman David Michery indicated that each of the individuals is vital and will be located across the company’s different facilities in California and Mississippi, Mullen’s Powertrain in Monrovia, and Mullen’s AMEC Manufacturing. “I am happy to announce the addition of these new members to the Mullen Automotive Team,” Michery said. “Every new team member is a vital hire and an integral part of our EV programs…

Continue Reading

WednesdayMay 18, 2022 12:45 pm

Blockchain Futurist Conference Continues To Grow with ETHToronto Hackathon as part of Canada’s Largest Blockchain Event

Witness a futuristic immersive experience at Blockchain Futurist Conference, Canada’s largest cryptocurrency and blockchain event being held from August 9-10th, 2022 at Rebel Entertainment Complex & Cabana, Toronto, Canada. This larger-than-life event will be held inside the 45,000 sq foot social playground and includes access to the outdoor cabana area of the spectacular waterfront venue. Connect with over 5,000 people from the crypto, blockchain, NFT, Metaverse, Defi, and DAOs world. Have a blast Networking and participating in panel discussions, keynote sessions, round tables, panels, workshops, and more. Blockchain Futurist Conference is currently building up their speaker roster and is anticipated…

Continue Reading

WednesdayMay 18, 2022 12:40 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Abstract to be Presented at American Society of Clinical Oncology 2022 Annual Meeting

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced acceptance of its abstract for poster presentation at the American Society of Clinical Oncology (“ASCO”) 2022 Annual Meeting. Being held virtually and in Chicago, Illinois, the event is slated to take place from June 3-7, 2022. The abstract is titled “Design and initiation of an adaptive, randomized, controlled study of berubicin, a topoisomerase 2 poison that crosses the blood brain barrier (‘BBB’), for the treatment of recurrent glioblastoma multiforme (‘GBM’) after first-line…

Continue Reading

WednesdayMay 18, 2022 12:30 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (SILO) CEO Featured in Bell2Bell Podcast Episode

Silo Pharma (OTCQB: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, and its founder and CEO Eric Weisblum are the center of attention in the most recent episode of the Bell2Bell Podcast. The Bell2Bell Podcast is designed to provide informative updates and exclusive interviews with executives operating in fast-moving industries. During the interview, hosted by Stuart Smith, Weisblum talks about his own background and experience in the industry as well as Silo Pharma’s business model and the company’s recent milestones. Weisman has been building and managing businesses for more than two decades and has…

Continue Reading

WednesdayMay 18, 2022 12:14 pm

QualityStocksNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) CEO to Share Expansion Strategy at H.C. Wainwright Conference

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today shared details regarding participation of its CEO Matt Stang at the H.C. Wainwright Annual Global Life Sciences Conference taking place May 23-26, 2022, in Miami, Florida. The four-day event will feature keynote presentations, investor one-on-one meetings, networking opportunities and evening entertainment. At this year's conference, Stang will present the company's expansion strategy and participate in one-on-one meetings. Interested parties should visit https://ibn.fm/UGjjp to register for the event. To view the full press release, visit https://ibn.fm/FJs7P About Delic Holdings Corp. Delic…

Continue Reading

WednesdayMay 18, 2022 12:00 pm

Diversity in Clinical Trials Summit Underscores Need for Targeting More Broadly Representative Patient Populations

The Diversity in Clinical Trials Summit presented by Dynamic Global Events (“DGE”) in June is an unequaled venue for your team to establish strategies ensuring that a diversity of patient populations are represented in the testing of new drug products.  A key element of conducting sound trials is ensuring that minority populations are included in the testing because they will comprise a portion of the affected patient profile, and may have unique responses to the trials.  But historically, clinical trials have excluded and overlooked them.    The Diversity in Clinical Trials Summit aims to re-center drug development around patient diversity in…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered